The monocyte/macrophage as a therapeutic target in atherosclerosis
Authors:
- Prakash SahaPSPrakash Saha
- Bijan ModaraiBMBijan Modarai
- Julia HumphriesJHJulia Humphries
- Katherine MattockKMKatherine Mattock
- Matthew WalthamMWMatthew Waltham
- Kevin G BurnandKBKevin G Burnand
- Alberto SmithASAlberto Smith
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 9 (2) , 109-118
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Identification of Neutral Cholesterol Ester Hydrolase, a Key Enzyme Removing Cholesterol from MacrophagesJournal of Biological Chemistry, 2008
- Induction of ABCA1 by overexpression of hormone-sensitive lipase in macrophagesBiochemical and Biophysical Research Communications, 2008
- Nanoparticle PET-CT Imaging of Macrophages in Inflammatory AtherosclerosisCirculation, 2008
- Release of protein as well as activity of MMP‐9 from unstable atherosclerotic plaques during percutaneous coronary interventionJournal of Internal Medicine, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Macrophage heterogeneity and tissue lipidsJournal of Clinical Investigation, 2007
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJournal of Clinical Investigation, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992